Luteolin attenuates allergic airway inflammation and epithelial injury in association with AMPKα signaling by regulating the balance of mitochondrial dynamics
Background Airway inflammation is one of the main pathological features of asthma. Luteolin is a natural flavonoid monomer with various pharmacological activities, including anti-inflammatory, antioxidant, and anti-tumor effects. However, the mechanism by which it regulates mitochondrial dynamics to ameliorate airway inflammation has not yet been fully elucidated. This study aimed to investigate the effects of luteolin on allergic airway inflammation and epithelial injury and to explore the potential involvement of AMPKα-associated signaling and mitochondrial regulation. Methods An ovalbumin (OVA)-induced asthmatic mouse model and a Lipopolysaccharide (LPS)-induced inflammatory model in BEAS-2B Cells were established. The levels of p-AMPKα, mitochondrial dynamics-related proteins (Opa1, Mfn1/2, Fis1), apoptosis-related markers (Caspase-3/Bax), reactive oxygen species (ROS), and interleukin (IL)-4, IL-5, and IL-13 were assessed by Western blotting, real-time quantitative PCR (RT-qPCR), and biochemical assays in both in vivo and in vitro experiments. Results In OVA-induced asthmatic mice, luteolin treatment was associated with reduced IgE and type 2 cytokine (IL-4, IL-5, and IL-13) levels, attenuated inflammatory cell infiltration, and decreased Penh responses. These changes were accompanied by increased expression of mitochondrial fusion-associated proteins (Mfn1, Mfn2, and Opa1), reduced expression of fission-associated markers (p-Drp1 and Fis1), and decreased oxidative stress and apoptosis-related indicators. In LPS-stimulated BEAS-2B Cells, luteolin improved mitochondrial morphology and function, reduced ROS accumulation and apoptosis, and decreased the levels of epithelial-derived inflammatory mediators. These effects were associated with increased AMPKα phosphorylation. Pharmacological interventions using AICAR and Compound C provided additional evidence suggesting the potential involvement of AMPK-associated signaling. Conclusion Luteolin attenuates allergic airway inflammation in OVA-induced asthmatic mice and protects BEAS-2B Cells against LPS-induced inflammatory injury. These protective effects are associated with AMPKα signaling and changes in mitochondrial dynamics-related markers. Further target-specific studies are required to establish the causal contribution of AMPKα to these effects.
Authors
- 邝枣园
- Zhengze Zhang (ORCID: https://orcid.org/0000-0003-2613-6224)
- Tong Wu (ORCID: https://orcid.org/0000-0001-6276-5197)
- Longfei Ding
- Yong Wang
- Hao Liu
- Yuewen He
- Wuhua Ma
Institutions
- Guangzhou University of Chinese Medicine (CN)
- First Affiliated Hospital of Guangzhou University of Chinese Medicine (CN)
- Affiliated Hospital of Shandong University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2026-11-20
- DOI
- https://doi.org/10.3389/fphar.2026.2005984
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00